Slingshot members are tracking this corporate initiative:
Pfizer (PFE) is set to purchase 5,000,000 of Homology’s (FIXX) common stock at a price of $12.00 per share
Do you think this event is important to the companies below? How will it affect their stock price?
“With the positive clinical data from the dose-escalation phase of our pheNIX Phase 1/2 trial for adults with phenylketonuria (PKU) and our plans to move to the expansion phase of the trial, both of which we announced last week, we believe Pfizer’s investment in Homology is a testament to their enthusiasm for our PKU gene therapy and gene editing programs to treat people living with this disease,” stated Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 09, 2020 Projected Implementation: Q4, 2020 Relevance Tracked Until: Q1, 2021
Don’t see a project related to the strategic initiative you care about?
Related Keywords Acquisition